JOSEPH KASS to United States Food and Drug Administration
This is a "connection" page, showing publications JOSEPH KASS has written about United States Food and Drug Administration.
Connection Strength
0.883
-
Prescribing Antipsychotic Medications to Patients With Dementia: Boxed Warnings and Mitigation of Legal Liability. Continuum (Minneap Minn). 2019 Feb; 25(1):254-259.
Score: 0.581
-
The Medicolegal and Ethical Dimensions of Physician Prescription Reluctance. Continuum (Minneap Minn). 2022 06 01; 28(3):937-941.
Score: 0.183
-
Cutaneous Adverse Effects of Neurologic Medications. CNS Drugs. 2016 Mar; 30(3):245-67.
Score: 0.119